{"nctId":"NCT00264875","briefTitle":"Open Label Safety And Efficacy Study Of Pregabalin In Subjects With Nerve Pain Asociated With Human Immunodeficiency Virus (HIV) Neuropathy","startDateStruct":{"date":"2006-02"},"conditions":["Peripheral Neuropathy","HIV Infections"],"count":220,"armGroups":[{"label":"1","type":"EXPERIMENTAL","interventionNames":["Drug: pregabalin"]}],"interventions":[{"name":"pregabalin","otherNames":[]}],"eligibilityModule":{"eligibilityCriteria":"Inclusion Criteria:\n\n* Participation in the preceding A0081066 double-blind trial met the entry criteria for that trial and completed A0081066 study through visit 7\n\nExclusion Criteria:\n\n* Experienced serious adverse event during the A0081066 trial that was considered related or possibly related to study medication by the investigator or sponsor\n* non-compliant during A0081066 trial\n* clinically significant or unstable medical condition both HIV-related and non-HIV related including but not limited to, cardiac, pulmonary or hepatorenal disease that, in the opinion of the investigator, would compromise participation in the study","healthyVolunteers":false,"sex":"ALL","minimumAge":"18 Years","stdAges":["ADULT","OLDER_ADULT"]},"locations":{"multicenter":true},"periods":[],"outcomeMeasures":[{"type":"PRIMARY","title":"Mean Visual Analogue Scale (VAS) Pain Scores","description":"Pain scores were assessed on a 100 mm Visual Analogue Scale (VAS); scores range from 0= no pain to 100= worse pain. Subjects assessed their pain during the last week.\n\nEndpoint = last non-missing observation carried forward after Baseline visit.","paramType":"MEAN","dispersionType":"Standard Deviation","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"38.61","spread":"27.10"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"30.75","spread":"25.19"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"30.16","spread":"25.78"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"28.95","spread":"26.05"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"29.39","spread":"26.32"}]}]}]}],"adverseEventsModule":{"adverseEventsSummary":{"seriousAny":{"events":10},"commonTop":["Dizziness","Somnolence","Peripheral edema","Diarrhea","Fatigue"]}}}